BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium - Butyrivibrio |
👶
Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota Scientific Reports (Sci Rep ) Vol: 7 Issue Pages: 8770 Pub: 2017 Aug 18 Epub: 2017 Aug 18 Authors Fang D , Shi D , Lv L , Gu S , Wu W , Chen Y , Guo J , Li A , Hu X , Guo F , Ye J , Li Y , Li L , Html Article Publication |
| bifidobacterium - Butyrivibrio |
👶
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , Html Article Publication |
| bifidobacterium - Butyrivibrio |
👶
Mouse intestinal microbiome modulation by oral administration of a GABA-producing Bifidobacterium adolescentis strain. Microbiology spectrum (Microbiol Spectr ) Vol: 12 Issue 1 Pages: e0258023 Pub: 2024 Jan 11 Epub: 2023 Nov 22 Authors Tamés H , Sabater C , Royo F , Margolles A , Falcón JM , Ruas-Madiedo P , Ruiz L , Html Article Publication |
| bifidobacterium - Butyrivibrio |
👶
Additional sources and private correspondance Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12 Pub: 2018 Epub: |
| bifidobacterium - Butyrivibrio |
👶
Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2018 Jul 5 Epub: 2018 Jul 5 Authors Wang K , Yu X , Li Y , Guo Y , Ge L , Pu F , Ma X , Cui W , Marrota F , He F , Li M , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
